Congenital heart disease in Down Syndrome focusing on atrioventricular septal defect: literature review
DOI:
https://doi.org/10.33448/rsd-v11i14.36602Keywords:
Down syndrome; Congenital Heart Defects; Endocardial cushion defects.Abstract
Down Syndrome is the most frequent aneuploidy in the world, with an incidence of 1 in every 700 live births. The most common characteristics of this population are intellectual disability, short stature, typical facial features and congenital malformations such as the atrioventricular septal defect, which is the most frequent. It occurs due to the poor development of the atrioventricular endocardial cushions, which is linked to the CRELD1 gene from the amplification of the gene dosage and the gene mutation, or also due to the malformation of the dorsal mesenchymal protrusion, from the formation of the atrioventricular junction. The diagnosis of this pathology becomes late because symptoms may be absent during the first days of life, leading to complications such as heart failure, pneumonia, cardiac arrhythmias or pulmonary hypertension and in some cases, only surgery is able to solve the problem. The aim of this study was to analyze the atrioventricular septal defect in people with Down Syndrome and congenital heart disease from the literature review.
References
Ackerman, C., et al. (2012) An Excess of Deleterious Variants in VEGF-A Pathway Genes in Down-Syndrome-Associated Atrioventricular Septal Defects. Am J Hum Genet. 91(4): 646-659.
Ahmed, I., & Anjum, F. (2022). Atrioventricular Septal Defect. Treasure Island (FL): StatPearls Publishing.
Belo, W. A., Oselame, G. B., & Neves, E. B. (2016). Perfil clínico-hospitalar de crianças com cardiopatia congênita. Cad Saúde Colet. 24(2): 216-220.
Benhaourech, S., Drighil, A., & Hammiri, A. E. (2016). Congenital heart disease and Down syndrome: various aspects of a confirmed association. Cardiovasc J Afr. 27(5): 287-290.
Bravo-Valenzuela, N. J. M., et al. (2011). Weight and height recovery in children with Down Syndrome and congenital heart disease. Rev Bras Cir Cardiovasc. 26(1): 61-8.
Briggs, L. E., Kakarla, J., & Wessels, A. (2012). The Pathogenesis of Atrial and Atrioventricular Septal Defects with Special Emphasis on the Role of the Dorsal Mesenchymal Protrusion. Differentiation. 84(1) :117-130.
Capurro, N. N., et al. (2020). Congenital anomalies and comorbidities in neonates with Down Syndrome. Rev Chil Pediatr. 91(5): 732-740.
Clausen, A. B., Garne, E., & Damkjaer, M. (2022). Live birth prevalence of atrioventricular septal defect after the implementation of new prenatal screening guidelines. Dan Med J. 13;69(2): A09210676.
Colvin, K. L., & Yegar, M. E. (2017). What people with Down Syndrome can teach us about cardiopulmonary disease. Eur Respir Rev. 26: 160098.
Corrêa, B. F. B., et al. (2022). Levantamento bibliográfico das principais cardiopatias congênitas associadas à Síndrome de Down no Brasil. Research, Society and Development. 11(6): e45611629167.
Correia, A. M., & Mesquita, A. (2014). Mestrados e Doutoramentos - Estratégias para a elaboração de trabalhos científicos: o desafio da excelência. (2ª. ed.): VidaEconómica.
Costa, A. B., & Zoltowski, A. P. C. (2014). Como escrever um artigo de revisão sistemática. p. 55-70. Koller, S., Couto, M., Hohendorff, J. Manual de produção científica. Porto Alegre: Penso.
Dias, F. M. A., et al. (2016). Cardiopatia Congénita em Crianças com Síndrome de Down: O que Mudou nas Últimas Três Décadas? Acta Med Port. 29(10): 613-620.
Estrela, C. (2018). Metodologia científica: ciência, ensino, pesquisa. Editora Artes Médicas.
Felice, B. E. L., Werneck, A. L., & Ferreira, D. L. M. (2021). Políticas Públicas: a importância da aplicabilidade efetiva para detecção precoce da cardiopatia congênita. Research, Society and Development. 10(11): e56101119371.
Hu, H., et al. (2017). A prospective clinical trial to compare the performance of driedblood spots prenatal screening for Down’s syndrome withconventional non-invasive testing technology. Experimental Biology and Medicine. 242: 547-55.
Izzo, A., et al. (2018). Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets. Mol Med. 15;24(1): 2.
Neves, R. A. M. S., et al. (2020). Cardiopatias congênitas: manifestações clínicas e tratamento. Rev Cien Online. 12(1).
Olariu, L. C., et al. (2021). Challenges in the Surgical Treatment of Atrioventricular Septal Defect in Children With and Without Down Syndrome in Romania-A Developing Country. Frontiers in pediatrics. 9(612644).
Pereira, A. S., et al. (2018). Metodologia da pesquisa científica. [free e-book]. Santa Maria/RS. Ed. UAB/NTE/UFMS.
Pfitzer, C., et al. (2018). Dynamics in prevalence of Down syndrome in children with congenital heart disease. Eur J Pediatr. 177(1): 107-115.
Plaiasu, V. (2017). Down Syndrome - Genetics and Cardiogenetics. Maedica (Bucur). 12(3): 208-213.
Ruz-Montes, M. A., et al. (2017). Cardiopatías congénitas más frecuentes en niños con síndrome de Down. Rev Colomb Cardiol. 24(1): 66-70.
Santos, F. C. G. B., et al. (2019). Surgical Treatment for Congenital Heart Defects in Down Syndrome Patients. Braz J Cardiovasc Surg. 34(1): 1-7.
Seither, K., et al. (2021). Neonatal complications of Down syndrome and factors necessitating intensive care. Am J Med Genet A. 185(2): 336-343.
Souza, D. M., et al. (2022). Vivências maternas após o diagnóstico de cardiopatia congênita infantil no filho com síndrome de Down. Rev baiana enferm. 36: e47287.
Versacci, P., et al. (2018). Cardiovascular disease in Down Syndrome. Curr Opin Pediatr. 30(5): 616-622.
Zhang, H., Liu, L., & Tian, J. (2019). Molecular mechanisms of congenital heart disease in down syndrome. Genes Dis. 6(4): 372–377.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Isadora Giacomino Alves; Isadora Mariah Menoia; Beatriz Pascoali Cunha; Caroline Vintiguera Pancera; Fernanda Sonza; Fernanda Yukari Tanaka de Melo; Edineu Lopes dos Santos Júnior; Cristiane Claudia Meinerzs; Irinéia Paulina Baretta; Rosiley Berton Pacheco
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.